We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Manual to Help Clinicians Better Diagnose and Treat Infection-Associated Chronic Illness

By LabMedica International staff writers
Posted on 20 Aug 2025

Infection-associated chronic illnesses (IACIs) such as long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and long Lyme disease are disabling, costly, and often misunderstood in medicine. More...

Millions of people worldwide live with these conditions, which are difficult to diagnose due to the absence of definitive biomarkers and complex symptom profiles. Despite rising cases, knowledge gaps and stigma persist, leaving many patients without adequate care. To address these challenges, a new resource has been created to equip clinicians with evidence-based practices and improve patient outcomes.

Mount Sinai Health System (New York, NY, USA) has introduced the first clinical manual in the US for treating IACIs, developed by the Cohen Center for Recovery from Complex Chronic Illnesses (New York, NY, USA). The guide incorporates extensive learnings from the Center’s clinical care and research programs, which lead trials for promising therapies and investigate the similarities and differences among patients with these conditions. The manual provides comprehensive instruction on diagnosis, long-term management strategies, multidisciplinary care models, and effective patient communication.

Drawing from the Center’s infrastructure and treatment approaches, the manual details infection prevention protocols such as the use of HEPA filters and germicidal far-UV light technology to minimize exposure during in-person visits. It also outlines physical therapy guidelines for conditions including Ehlers-Danlos syndrome, dysautonomia, and craniocervical instability. Importantly, it warns against incorrectly prescribed cardiovascular exercise, which may harm patients experiencing post-exertional malaise.

The manual covers the care of common manifestations like brain fog, mast cell activation, and post-exertional malaise, while also presenting a molecular-level perspective on the biological processes behind diverse clinical presentations. These insights help explain why certain symptoms arise and provide clinicians with tools to develop targeted care strategies.

Reviewed by more than a dozen national and international experts, the manual ensures global relevance and practical usability. Going forward, Mount Sinai plans to support clinicians worldwide by making the manual freely accessible online. In addition, the Center will provide supplementary resources such as CME-accredited courses, events, and educational programs to strengthen adoption.

“Infection-associated chronic illnesses remain disabling, costly, and widely misunderstood across much of medicine,” said Raven Baxter, PhD, Director of Science Communication at the Cohen Center for Recovery from Complex Chronic Illnesses at Mount Sinai. “Recent research from our team shows that even a single well-designed educational intervention can dramatically increase clinicians’ confidence, preparedness, and empathy in managing these conditions.”

Related Links:
Mount Sinai Health System
Cohen Center for Recovery from Complex Chronic Illnesses


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Neuron-derived extracellular vesicles carry many biomarker candidates for Alzheimer’s (S Chinnathambi et al., Brain Network Disorders (2025). doi.org/10.1016/j.bnd.2024.12.006)

Neuron-Derived Extracellular Vesicles Could Improve Alzheimer’s Diagnosis

Alzheimer’s disease is becoming increasingly common as global populations age, yet effective treatments for advanced stages remain limited. Early detection is therefore critical, but current diagnostic... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.